Clare Fisher

Clare Fisher joined BeiGene in July 2021 as SVP Business Development & Mergers and Acquisitions, bringing over 20 years of experience in healthcare, including leadership roles in corporate and business development, M&A. and strategy. Prior to joining BeiGene, Ms. Fisher served as Kaleido Bioscience’s Chief Business Officer. Ms. Fisher previously also held senior global roles at Shire plc, Cubist Pharmaceuticals, Blueprint Medicines, and Genzyme Corporation leading collaborations, licensing, M&A, and divestments across many technologies and therapeutic areas. Ms. Fisher holds a B.S. in Biochemistry from the University of Bath, as well as an M.B.A. from Henley Management College in the U.K.